Latest updates from Peptxis and the peptide industry
We are excited to announce the completion of our expanded manufacturing facility in Guangdong Province. The new state-of-the-art production line increases our annual peptide output by 40%, enabling us to better serve the growing global demand for high-purity research peptides.
Read More
We are thrilled to add Tirzepatide 10mg and Retatrutide 20mg to our research peptide catalog. Both products undergo rigorous HPLC and mass spec testing to guarantee 99%+ purity.
Read More
A new strategic partnership brings Peptxis research peptides to laboratories across Europe, expanding our reach and supporting cutting-edge scientific research worldwide.
Read More
Get to know the dedicated researchers and quality control specialists who ensure every Peptxis product meets the highest standards of purity and consistency.
Read More
An in-depth look at how GLP-1 receptor agonist peptides like Tirzepatide and Retatrutide are revolutionizing metabolic disease research and therapeutic development.
Read MoreSubscribe to receive updates on new products, research insights, and company news from Peptxis.